2006, Drugs and Testimonials - Drug Discovery Digest

SAVE THE DATE: Drug Channels Leadership Forum, March 16-18, 2026

Drug Channels

APRIL 24, 2025

After a blockbuster inaugural event and tremendous feedback from attendees, were excited to announce that the Drug Channels Leadership Forum (DCLF) returns on March 1618, 2026 , at the Turnberry Resort & Spa in Miami. Request Your Invitation Id recommend the DCLF to anyone in the drug industry in the US. Cant see the video above?

Pharmacy

Pharmacy Testimonials Drugs Pharmaceuticals

Article FDA Thank You Congress prepares to markup pandemic legislation, all but confirming FDA-related provisions won’t advance

Agency IQ

JULY 13, 2023

BY LAURA DIANGELO, MPH JUL 12, 2023 7:14 PM CDT Quick background: the Pandemic and All-Hazards Preparedness Act The Pandemic and All-Hazards Preparedness Act (PAHPA) was originally passed in 2006. Republicans have also indicated that legislation focused on drug shortages is proceeding separately.

FDA

FDA Packaging Laboratories Testimonials

Analysis Life Sciences Thank You Everything the FDA is planning to do in Q3 2023

Agency IQ

JULY 28, 2023

DSCSA implementation – Down to the wire as a deadline draws near: The Drug Supply Chain Security Act (DSCSA) was enacted in 2013 as part of the Drug Quality and Security Act (DQSA), following several drug counterfeiting scandals in which falsified medical products entered the supply chain.

FDA

FDA Science Biosimilars Regulations

Analysis Chemical Thank You Overview of the U.S. regulation of PFAS

Agency IQ

OCTOBER 20, 2023

Data from the 2012, 2016, and 2020 CDR and 1998, 2002, and 2006 Inventory Update Reporting (IUR) Rule are included in the PFAS Analytic Tools. While there are a variety of reporting thresholds, sites manufacturing or importing 25,000 pounds or more of a chemical substance in a given year are required to report to CDR.

Regulations

Regulations Production Packaging Treatment

Origins of the Lab Mouse

Codon

JUNE 2, 2024

Without mouse models, we may never have developed polio and meningitis vaccines, organ transplants, GLP-1 drugs, gene therapies , or any other number of transformative treatments. Adapted from Yoshiki and Moriwaki (2006). In a testimony in front of the U.S. Origins of mice used in research. Image Credit: JAX Handbook.

Laboratories

Laboratories Research Disease Science

Let's Quit Sugar With Audiobook – Let's Quit Sugar

The Pharma Data

MAY 13, 2021

Testimonials are not necessarily representative of all of those who will use our products. Some of our testimonials are provided by customers who have received promotional offers in exchange for their participation. The testimonials displayed are given verbatim except for correction of grammatical or typing errors. Pediatr Ann.

Disease

Disease Production Testimonials Science

Dealing with the Pennsylvania Supreme Court’s Non-Decision on Standards Compliance Evidence

Drug & Device Law

JANUARY 15, 2024

2d 888 (1996) (manufacturer immune from strict liability defective design claim premised upon sale of prescription drugs without adequate warning). Thus (unless and until the Dormant Commerce Clause puts a stop to it) any plaintiff anywhere in the country can sue Pennsylvania-registered drug or device manufacturers in Pennsylvania courts.

Compliance

Compliance Government Production FDA Compliance

The FDA and Feasible Alternative Designs

Drug & Device Law

FEBRUARY 20, 2023

Drug manufacturers often could trade a little less efficacy for a little more safety, but the safest design is not always the best one. to determine whether a proposed alternative drug would have received FDA approval.” 2006), app. For physicians to prescribe such a safer drug, it must reach the market. 2d 506 (N.Y.

FDA

FDA FDA Approval Testimonials Vaccine

Confident Learned Intermediaries Defeat Warning Causation

Drug & Device Law

JUNE 6, 2022

Thus a confident learned intermediary’s testimony will defeat causation as a matter of law by stating that, notwithstanding a poor result, the treatment provided was standard of care, and even in hindsight they would not do anything different. Confident learned intermediaries stand by their medical decisions. Medrano , 28 S.W.3d 3d 75 (Fla.

Testimonials

Testimonials Production Pharmaceuticals Drugs

Unimpressed Learned Intermediaries Defeat Warning Causation

Drug & Device Law

MAY 30, 2022

That means that prescribers can make risk/benefit analyses to determine what prescription drugs or medical devices their patients need. The prescriber’s] testimony, however, does not establish that he would have altered his prescribing conduct. That “common and widely known side effect” of many “chemotherapy drugs,” id.

Testimonials

Testimonials Doctors Production Laboratories

New York Court of Appeals Holds that Plaintiff Did Not Prove Causation in Talc/Asbestos Mesothelioma Case

Drug & Device Law

APRIL 29, 2022

We write on a chilly day in Philadelphia – we and the Drug and Device Law Little Rescue Dogs all shivered on our morning walk. On appeal, the intermediate appellate court affirmed, holding that “[the geologist’s] testimony about the amount of asbestos released. 2d 1114 (2006). The trial court denied the motion. 2d 584, 857 N.E.2d

Testimonials

Testimonials International Production Doctors

Not the Best Wisconsin Law Decision We’ve Ever Seen

Drug & Device Law

APRIL 18, 2022

The surgeon’s testimony supported two grounds for non-causation: lack of reliance, and that a warning would not have changed how the prescription product was used. 2006) (rejecting distinction between “a case of no warning as opposed to an inadequate warning”), aff’d , 526 F.3d Nothing about what does or does not “inform” prescribers.

Testimonials

Testimonials Production FDA Approval FDA

Drug Discovery Digest

SAVE THE DATE: Drug Channels Leadership Forum, March 16-18, 2026

Article FDA Thank You Congress prepares to markup pandemic legislation, all but confirming FDA-related provisions won’t advance

Trending Sources

Analysis Life Sciences Thank You Everything the FDA is planning to do in Q3 2023

Analysis Chemical Thank You Overview of the U.S. regulation of PFAS

Origins of the Lab Mouse

Let's Quit Sugar With Audiobook – Let's Quit Sugar

Dealing with the Pennsylvania Supreme Court’s Non-Decision on Standards Compliance Evidence

The FDA and Feasible Alternative Designs

Confident Learned Intermediaries Defeat Warning Causation

Unimpressed Learned Intermediaries Defeat Warning Causation

New York Court of Appeals Holds that Plaintiff Did Not Prove Causation in Talc/Asbestos Mesothelioma Case

Not the Best Wisconsin Law Decision We’ve Ever Seen

Stay Connected